Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and Infection.
Journal article
Frost JN. et al, (2021), Med (N Y), 2, 164 - 179.e12
A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses.
Journal article
Tan TK. et al, (2021), Nat Commun, 12
Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.
Journal article
Huo J. et al, (2020), Nat Struct Mol Biol, 27
Overcoming Symmetry Mismatch in Vaccine Nanoassembly through Spontaneous Amidation
Journal article
Rahikainen R. et al, (2020), Angewandte Chemie
Micro-fusion inhibition tests: quantifying antibody neutralization of virus-mediated cell-cell fusion.
Journal article
Thakur N. et al, (2020), J Gen Virol
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike.
Journal article
Huo J. et al, (2020), Cell Host Microbe, 28
Overcoming Symmetry Mismatch in Vaccine Nanoassembly via Spontaneous Amidation.
Journal article
Howarth M. et al, (2020), Angew Chem Int Ed Engl
Lung-targeting lentiviral vector for passive immunisation against influenza.
Conference paper
Tan TK. et al, (2020), Thorax
Lung-targeting lentiviral vector for passive immunisation against influenza
Journal article
TAN TK. et al, (2020), Thorax
Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient.
Journal article
Zhou D. et al, (2020), Nat Struct Mol Biol
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.
Journal article
Huo J. et al, (2020), Nat Struct Mol Biol
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike.
Journal article
Huo J. et al, (2020), Cell Host Microbe
Lung targeting lentiviral vector for passive immunisation against influenza
Working paper
TAN T. et al, (2020)
Lentiviral-Mediated Expression of Monoclonal Antibodies in the Lung to Protect Against Influenza
Conference paper
Du Y. et al, (2020), MOLECULAR THERAPY, 28, 60 - 60
An improved method for the rescue of recombinant Newcastle disease virus.
Journal article
Cheow P-S. et al, (2020), Biotechniques, 68, 96 - 100
Broadly Inhibiting Antineuraminidase Monoclonal Antibodies Induced by Trivalent Influenza Vaccine and H7N9 Infection in Humans.
Journal article
Rijal P. et al, (2020), J Virol, 94
A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy.
Journal article
Miao X. et al, (2020), MAbs, 12
Coupling AAV-mediated promoterless gene targeting to SaCas9 nuclease to efficiently correct liver metabolic diseases
Conference paper
De Caneva A. et al, (2018), HUMAN GENE THERAPY, 29, A115 - A115
Use of Pseudotyped, Replication-Deficient Influenza to Facilitate Testing of Gene Delivery Strategies for Treatment of Highly Infectious Diseases
Conference paper
Tan TK. et al, (2018), MOLECULAR THERAPY, 26, 242 - 243